Carboxyl Iron Oxide Nanoparticles

SKU:BHD12200041
Overview
Click light‑blue chips for details
Carboxyl-functionalized superparamagnetic iron oxide nanoparticles (5–30 nm) with carboxylic acid surface groups for EDC/NHS-mediated amine coupling. Applied to MRI/MPI imaging, magnetic sensing for IVD, drug delivery, immunotherapy, and vaccine adjuvant research.
Particle Type Iron Oxide Nanoparticle
Surface Chemistry Carboxyl
Particle Size 5 nm–30 nm
Conjugation Type Activated (Ready-to-conjugate)
Dispersion Aqueous
Applications MRI Imaging, Magnetic Particle Imaging, Drug Delivery
Options selector
Catalog no. Particle Size Volume
SHP05-02 5 nm
SHP10-02 10 nm
SHP15-02 15 nm
SHP20-02 20 nm
SHP25-02 25 nm
SHP30-02 30 nm
Combo-SHP-3 Combo Pack, any three (3) sizes from 10 nm to 30 nm
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Particle Size (6 options): 10 nm, 15 nm, 20 nm, 25 nm, 30 nm, 5 nm; Combo Pack available | Volume (3 options): 10 mL, 2 mL, 3 x 2 mL
  • Lead time: varies by selected option; please contact us for current fulfillment timing.
  • Storage: Store at 2-8°C.
  • Shipping: ambient temperature shipment.
  • Upon receipt: inspect packaging; record lot number; allow product to reach appropriate working temperature per the product datasheet before use.
  • Sales terms and conditions: all sales are subject to BioHippo's standard Terms and Conditions.
Field Specification
Mfr No SHP05, SHP10, SHP15, SHP20, SHP25, SHP30, Combo-SHP-3
Concentration 5 mg/mL
Form liquid
Molecular Weight Varies
Product Type
  • Beads & Nanoparticles
  • Nanoparticles
  • Iron Oxide Nanoparticles
Relative Density 1.00 g/cm3
Shipping Ambient Temperature
Storage Store at 2-8°C.

Overview

These Carboxyl Iron Oxide Nanoparticles are superparamagnetic particles with excellent colloidal stability and biocompatible coating for biomedical applications including: in-vivo magnetic resonance imaging (MRI), magnetic particles imaging (MPI), magnetic sensing for in-vitro diagnostics, small molecular drug delivery, immunotherapy, hyperthermia, adjuvant for vaccine, etc. These particles are nanosized (5-30 nm) iron oxide nanoparticles with carboxylic acid groups. Oligonucleotides, antibodies, or other ligands with amine groups can be easily coupled to the nanoparticles. Activation through EDC is required. With excellent colloidal stability and unique surface coating, the carboxyl magnetic nanoparticles exhibit good binding capacity and low non-specific binding of protein or nucleic acids.

These Carboxyl Iron Oxide Nanoparticles are also available in an easy-to-use kit format to make it easier for researchers to conjugate antibodies, proteins, peptides or other biomolecules of their own choice to these magnetic iron oxide nanoparticles. The kit contains sufficient reagents and components for performing 5 conjugation reactions using 1 mg magnetic iron oxide nanoparticles per reaction. Briefly, the magnetic iron oxide nanoparticles are conjugated to amine groups that are present on the target protein/ligand using carbodiimide.

Key Features

  • Narrow size distribution
  • High colloidal stability
  • Low non-specific binding
  • Easy conjugation
  • Easy purification with magnetic column developed by Ocean NanoTech

Applications

  • In-vivo magnetic resonance imaging (MRI)
  • Magnetic particles imaging (MPI),
  • Magnetic sensing for in-vitro diagnostics
  • Small molecular drug delivery
  • Immunotherapy
  • Hyperthermia
  • Adjuvant for vaccine

Physical & Chemical Properties

  • Zeta Potential: from -30 mV to -45 mV
  • pH: 6.0 - 8.0 at 25 °C (77 °F)
  • Water Solubility: Completely miscible
  • Chemical Stability: Stable under recommended storage conditions.
  • Incompatible Materials: Strong oxidizing agents
  • Appearance / Color: brown/black

These are superparamagnetic iron oxide nanoparticles (5–30 nm, 10 mg/mL) with carboxylic acid (–COOH) surface groups for aqueous bioconjugation. Coupling uses EDC (with optional NHS) to activate the carboxyl groups, forming reactive intermediates that bind primary amines (–NH₂) on antibodies, proteins, oligonucleotides, or peptides to create stable amide bonds.

Any amine-bearing biomolecule can be coupled, including IgG antibodies (via lysine residues), streptavidin, BSA, peptides, and amine-modified DNA/RNA. Activation through EDC is required; adding Sulfo-NHS to the activation step improves conjugation efficiency at neutral pH.

Applications include MRI/MPI contrast enhancement, magnetic sensing for IVD, targeted drug delivery, immunotherapy, magnetic hyperthermia, and vaccine adjuvant research. The small nanoparticle size (5–30 nm) supports superparamagnetic behavior critical for MRI and MPI.

Yes — Carboxyl Iron Oxide Nanoparticles Conjugation Kits providing all EDC activation and coupling reagents for five complete conjugation reactions are available separately. See the Documents section for the kit specification sheet and conjugation protocol.

Typical approaches include Bradford/BCA protein assay on the supernatant to measure conjugation efficiency, gel electrophoresis of eluted conjugate, or a functional binding assay. A purification step using a magnetic column or centrifugation to remove unconjugated protein is recommended before the assay.

The following customization and add-on services are available for this product through the supplier. For inquiries and pricing, contact support@biohippo.com.

Customization Options

  • Custom Particle Sizes: Magnetic beads in sizes beyond the standard catalog range, with narrow size distribution from nanometers to micrometers, can be manufactured for specific assay geometries and separation requirements.
  • Custom Surface Functionalization: Customized surface coatings and functional group densities are available to optimize binding capacity, non-specific binding profiles, and colloidal stability for specific applications.
  • Custom Conjugation Service: Pre-conjugated magnetic bead–antibody, bead–protein, or bead–streptavidin conjugates prepared using your supplied biomolecule are available. The supplier specializes in bioconjugation chemistry across magnetic beads, iron oxide nanoparticles, quantum dots, and latex beads.
  • Assay Development Services: Support for magnetic bead-based chemiluminescent assay, lateral flow immunoassay, and custom immunoassay platform development is available.
  • Bulk & OEM Manufacturing: OEM magnetic beads for chemiluminescent assay, lateral flow immunoassay, CTC (circulating tumor cell) isolation for liquid biopsy, and T-cell isolation and activation for immunotherapy are available at production scale.

To inquire about customization options, request a quote, or discuss OEM manufacturing, contact support@biohippo.com.

  1. Rezaei E et al. (2026). A deep dive into ferritin nanoparticle advancements: experimental and computational perspectives. Discov Nano. DOI: 10.1186/s11671-026-04577-8 PMID: 42018247
  2. Amaolo A et al. (2026). Breaking Through the Barrier: Nanoparticle-Driven MRI Strategies for Diagnosis and Therapy of Pancreatic Cancer. ACS Nanosci Au. DOI: 10.1021/acsnanoscienceau.5c00116 PMID: 42004273
  3. Fan Y et al. (2026). Bio-magnetic nanomedicine for targeted drug delivery of breast cancer: green synthesis, functional design, and translational challenges. Breast Cancer Res. DOI: 10.1186/s13058-026-02278-9 PMID: 42002783
  4. Tashkandi J et al. (2025). Comparative evaluation of polymer coated versus antibody modified SPIONs for tumor detection using magnetic particle imaging. Nanoscale. DOI: 10.1039/d5nr00608b PMID: 40522141
  5. Al-Abboodi A et al. (2026). Iron-oxide nanoparticles (SPIONs) enhance malaria vaccine antibody response. Vaccine. DOI: 10.1016/j.vaccine.2026.128353 PMID: 41713326
  6. Morais B et al. (2026). Integrating green chemistry into SPION development: a theranostic study on prostate cell models. Nanoscale. DOI: 10.1039/d6nr00113k PMID: 41954586
  7. Aydın EB et al. (2025). Early and sensitive diagnosis of celiac autoimmune disease by using carboxylic acid functionalized magnetic nanoparticles-assisted biosensing platform. Mikrochim Acta. DOI: 10.1007/s00604-025-07129-6 PMID: 40198415
  8. Dong J et al. (2026). Advancements in nanomaterials for the treatment and management of vascular surgeries: from drug delivery to biomedical implants. Front Bioeng Biotechnol. DOI: 10.3389/fbioe.2026.1788897 PMID: 41953561

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today